Silence Therapeutics (SLN) Shareholder's Equity (2018 - 2026)

Silence Therapeutics (SLN) Shareholder's Equity (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 7.14 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 595,226.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - 502.95 Mn
10 Silence Therapeutics 966.41 Mn 896.33 Mn 411,000.00 49.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 49.40 Mn
Dec 31, 2025 62.30 Mn
Sep 30, 2025 74.06 Mn
Jun 30, 2025 94.16 Mn
Mar 31, 2025 112.74 Mn
Dec 31, 2024 134.02 Mn
Sep 30, 2024 126.70 Mn
Jun 30, 2024 142.53 Mn
Mar 31, 2024 156.76 Mn
Dec 31, 2023 21.16 Mn
Dec 31, 2022 25.89 Mn
Dec 31, 2021 11.49 Mn
Dec 31, 2020 11.96 Mn
Dec 31, 2019 26.88 Mn
Dec 31, 2018 45.11 Mn